Abstract
The complex development of the facial skeleton and the presence of odontogenic tissue contribute to the formation of a variety of cysts, tumors, and pathologic conditions that are either unique or occur more often in this region in the pediatric age group. Tumors of the maxillofacial region in children are generally infrequent and may represent a variety of clinical and pathologic entities. The rarity of these conditions explains the lack of numerous comprehensive case series that specifically address pediatric maxillofacial pathology. Nevertheless, the maxillofacial surgeon should be familiar with at least the most commonly encountered cysts and tumors, odontogenic or non-odontogenic in origin, their behavior, and the appropriate treatment protocols. Even more important is an understanding of the potential outcomes of treatment of these conditions in the immature, developing child. It is the purpose of this chapter to provide a comprehensive review of pediatric maxillofacial pathology along with the currently available treatment recommendations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Philipsen HP, Reichart PA. Classification of odontogenic tumours. A historical review. J Oral Pathol Med. 2006;35:525–9.
Kramer IR, Pindborg JJ, Shear M. The WHO histological typing of Odontogenic Tumours. A commentary on the second edition. Cancer. 1992;70:2988–94.
Tanaka N, Murata A, Yamaguchi A, Kohama G. Clinical features and management of oral and maxillofacial tumors in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:11–5.
Avelar RL, Antunes AA, Carvalho RW, et al. Odontogenic cysts: a clinicopathological study of 507 cases. J Oral Sci. 2009;51:581–6.
Marx RE, Stern D. Odontogenic and non odontogenic cysts. Chicago: Quintessence Publishing; 2003.
Regezi JA, Sciubba JJ, Jordan RCK. Cysts of the jaws and the neck. St. Louis: Saunders an imprint of Elsevier; 2003.
Sapp J, Eversole LR, Wysocki GP. Odontogenic cysts. St. Louis: Mosby; 1997.
Muller S. Update from the 4th edition of the World Health Organization of head and neck tumours: tumours of the oral cavity and mobile tongue. Head Neck Pathol. 2017;11:33–40.
Wenig B. Neoplasms of the oral cavity, nasopharynx, oropharynx and neck. Saunders an imprint of Elsevier; 2008.
Zhang J, Gu Z, Jiang L, et al. Ameloblastoma in children and adolescents. Br J Oral Maxillofac Surg. 2010;48(7):549–54.
Ord RA, Blanchaert RH Jr, Nikitakis NG, Sauk JJ. Ameloblastoma in children. J Oral Maxillofac Surg. 2002;60:762–70; discussion, 770–61.
Troulis MJ, Kaban LB. Jaw tumors in children. Philadelphia: Saunders an Imprint of Elsevier; 2004.
Marx RE, Stern D. Odontogenic tumors: hamartomas and neoplasms. Chicago: Quintessence Publishing; 2003.
Huang IY, Lai ST, Chen CH, et al. Surgical management of ameloblastoma in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:478–85.
Olaitan AA, Adekeye EO. Clinical features and management of ameloblastoma of the mandible in children and adolescents. Br J Oral Maxillofac Surg. 1996;34:248–51.
Melrose RJ. Benign epithelial odontogenic tumors. Semin Diagn Pathol. 1999;16:271–87.
Swasdison S, Dhanuthai K, Jainkittivong A, Philipsen HP. Adenomatoid odontogenic tumors: an analysis of 67 cases in a Thai population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:210–5.
Regezi JA, Sciubba JJ, Jordan RCK. Odontogenic tumors. St. Louis: Saunders an imprint of Elsevier; 2003.
Madras J, Lapointe H. Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour. J Can Dent Assoc. 2008;74:165.
Kolokythas A, Fernandes RP, Pazoki A, Ord RA. Odontogenic keratocyst: to decompress or not to decompress? A comparative study of decompression and enucleation versus resection/peripheral ostectomy. J Oral Maxillofac Surg. 2007;65:640–4.
Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers. Oral Oncol. 2002;38:407–15.
Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. Oral Oncol. 2002;38:323–31.
Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. Oral Oncol. 2002;38:219–26.
August M, Faquin WC, Troulis MJ, Kaban LB. Dedifferentiation of odontogenic keratocyst epithelium after cyst decompression. J Oral Maxillofac Surg. 2003;61:678–83; discussion 683-674.
Blanas N, Freund B, Schwartz M, Furst IM. Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:553–8.
Piattelli A, Fioroni M, Rubini C. Differentiation of odontogenic keratocysts from other odontogenic cysts by the expression of bcl-2 immunoreactivity. Oral Oncol. 1998;34:404–7.
Suyama Y, Kubota Y, Yamashiro T, et al. Expression of keratinocyte growth factor and its receptor in odontogenic keratocysts. J Oral Pathol Med. 2009;38:476–80.
Oka S, Kubota Y, Yamashiro T, et al. Effects of positive pressure in odontogenic keratocysts. J Dent Res. 2005;84:913–8.
Ninomiya T, Kubota Y, Koji T, Shirasuna K. Marsupialization inhibits interleukin-1alpha expression and epithelial cell proliferation in odontogenic keratocysts. J Oral Pathol Med. 2002;31:526–33.
Kubota Y, Nitta S, Oka S, et al. Discrimination of ameloblastomas from odontogenic keratocysts by cytokine levels and gelatinase species of the intracystic fluids. J Oral Pathol Med. 2001;30:421–7.
Mendes RA, Carvalho JF, Waal IV. Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment – an overview. Oral Oncol. 2010;46:19–24.
Dong Q, Pan S, Sun LS, Li TJ. Orthokeratinized odontogenic cyst: a clinicopathologic study of 61 cases. Arch Pathol Lab Med. 2010;134:271–5.
Adebayo ET, Ajike SO, Adekeye EO. Odontogenic tumours in children and adolescents: a study of 78 Nigerian cases. J Craniomaxillofac Surg. 2002;30:267–72.
Butt FM, Chindia ML, Wakoli KA. Problems in diagnosing odontogenic myxoma: case report. East Afr Med J. 2007;84:141–5.
Wachter BG, Steinberg MJ, Darrow DH, et al. Odontogenic myxoma of the maxilla: a report of two pediatric cases. Int J Pediatr Otorhinolaryngol. 2003;67:389–93.
Kaban L, Troulis MJ. Dentoalveolar surgery. Philadelphia: Saunders an imprint of Elsevier; 2004.
Chen Y, Li TJ, Gao Y, Yu SF. Ameloblastic fibroma and related lesions: a clinicopathologic study with reference to their nature and interrelationship. J Oral Pathol Med. 2005;34:588–95.
de Oliveira BH, Campos V, Marcal S. Compound odontoma--diagnosis and treatment: three case reports. Pediatr Dent. 2001;23:151–7.
Kanahara N, Nakakura K, Tomizawa M, Noda T. Clinical studies on 16 cases of odontoma in children. Shoni Shikagaku Zasshi. 1989;27:546–55.
Pogrel MA. Calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg. 2003;61:649–53; discussion 653-644.
Pogrel MA, Regezi JA, Harris ST, Goldring SR. Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases. J Oral Maxillofac Surg. 1999;57:848–53.
O’Malley M, Pogrel MA, Stewart JC, et al. Central giant cell granulomas of the jaws: phenotype and proliferation-associated markers. J Oral Pathol Med. 1997;26:159–63.
Pogrel MA. The management of lesions of the jaws with liquid nitrogen cryotherapy. J Calif Dent Assoc. 1995;23:54–7.
Wendt FP, Torriani MA, Gomes AP, et al. Intralesional corticosteroid injection for central giant cell granuloma: an alternative treatment for children. J Dent Child (Chic). 2009;76:229–32.
Flaitz CM. Peripheral giant cell granuloma: a potentially aggressive lesion in children. Pediatr Dent. 2000;22:232–3.
Bodner L, Bar-Ziv J. Radiographic features of central giant cell granuloma of the jaws in children. Pediatr Radiol. 1996;26:148–51.
Piekarczyk J, Kozlowski K. Central giant cell reparative granuloma of the mandible in children (report of four cases). Australas Radiol. 1984;28:149–51.
Regezi JA, Sciubba JJ, Jordan RCK. Benign nonodontogenic tumors. St. Louis: Saunders an imprint of Elsevier; 2003.
Kaban LB, Dodson TB. Management of giant cell lesions. Int J Oral Maxillofac Surg. 2006;35:1074–5; author reply 1076.
Padwa BL, Denhart BC, Kaban LB. Aneurysmal bone cyst-“plus”: a report of three cases. J Oral Maxillofac Surg. 1997;55:1144–52.
Eckardt A, Pogrel MA, Kaban LB, et al. Central giant cell granulomas of the jaws. Nuclear DNA analysis using image cytometry. Int J Oral Maxillofac Surg. 1989;18:3–6.
Ficarra G, Kaban LB, Hansen LS. Central giant cell lesions of the mandible and maxilla: a clinicopathologic and cytometric study. Oral Surg Oral Med Oral Pathol. 1987;64:44–9.
Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg. 1986;44:708–13.
Chuong R, Kaban LB. Diagnosis and treatment of jaw tumors in children. J Oral Maxillofac Surg. 1985;43:323–32.
Corbetta S, Rossi D, D’Orto O, et al. Brown jaw tumors: today’s unusual presentation of primary hyperparathyroidism. J Endocrinol Investig. 2003;26:675–8.
Unlu RE, Abaci E, Kerem M, et al. Brown tumor in children with normocalcemic hyperparathyroidism: a report of two cases. J Craniofac Surg. 2003;14:69–73.
Sanchez CP. Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment. Paediatr Drugs. 2003;5:763–76.
Levard G, Gaudelus J, Cessans C. Primary hyperparathyroidism in children. Ann Chir. 1992;46:653–8.
Glorieux FH, Rauch F. Medical therapy of children with fibrous dysplasia. J Bone Miner Res. 2006;21(Suppl 2):P110–3.
Plotkin H, Rauch F, Zeitlin L, et al. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab. 2003;88:4569–75.
Isaia GC, Lala R, Defilippi C, et al. Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia. Calcif Tissue Int. 2002;71:121–8.
Matarazzo P, Lala R, Masi G, et al. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2002;15(Suppl 3):929–37.
Maher CO, Friedman JA, Meyer FB, et al. Surgical treatment of fibrous dysplasia of the skull in children. Pediatr Neurosurg. 2002;37:87–92.
Lala R, Matarazzo P, Bertelloni S, et al. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr. 2000;89:188–93.
Pensler JM, Langman CB. Metabolic changes in osteoclasts isolated from children with fibrous dysplasia. DNA Cell Biol. 1993;12:411–4.
Di Rocco C, Marchese E, Velardi F. Fibrous dysplasia of the skull in children. Pediatr Neurosurg. 1992;18:117–26.
Georgiade N, Masters F, Horton C, Pickrell K. Ossifying fibromas (fibrous dysplasia) of the facial bones in children and adolescents. J Pediatr. 1955;46:36–43.
Regezi JA, Sciubba JJ, Jordan RCK. Metabolic and Genetic Diseases. St Louis: Saunders and imprint of Elsevier; 2003.
Carvalho Silva E, Carvalho Silva GC, Vieira TC. Cherubism: clinicoradiographic features, treatment, and long-term follow-up of 8 cases. J Oral Maxillofac Surg. 2007;65:517–22.
Yamaguchi T, Dorfman HD, Eisig S. Cherubism: clinicopathologic features. Skelet Radiol. 1999;28:350–3.
Cornelius EA, McClendon JL. Cherubism – hereditary fibrous dysplasia of the jaws. Roentgenographic features. Am J Roentgenol Radium Ther Nucl Med. 1969;106:136–43.
Frassica FJ, Waltrip RL, Sponseller PD, et al. Clinicopathologic features and treatment of osteoid osteoma and osteoblastoma in children and adolescents. Orthop Clin North Am. 1996;27:559–74.
Kwon PH, Horswell BB, Gatto DJ. Desmoplastic fibroma of the jaws: surgical management and review of the literature. Head Neck. 1989;11:67–75.
Comfort AO. Burkitt’s lymphoma of the jaws: role of dental practitioner in management. Pac Health Dialog. 2004;11:89–93.
Jan A, Vora K, Sandor GK. Sporadic Burkitt’s lymphoma of the jaws: the essentials of prompt life-saving referral and management. J Can Dent Assoc. 2005;71:165–8.
Ziegler JL, Wright DH, Kyalwazi SK. Differential diagnosis of Burkitt’s lymphoma of the face and jaws. Cancer. 1971;27:503–14.
Judson SC, Henle W, Henle G. A cluster of Epstein-Barr-virus-associated American Burkitt’s lymphoma. N Engl J Med. 1977;297:464–8.
Burkitt DP. Classics in oncology. A sarcoma involving the jaws in African children. CA Cancer J Clin. 1972;22:345–55.
Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46:218–23.
Ziegler JL. Treatment results of 54 American patients with Burkitt’s lymphoma are similar to the African experience. N Engl J Med. 1977;297:75–80.
Grifo AH. Langerhans cell histiocytosis in children. J Pediatr Oncol Nurs. 2009;26:41–7.
Stalemark H, Laurencikas E, Karis J, et al. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51:76–81.
Lau LM, Stuurman K, Weitzman S. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors. Pediatr Blood Cancer. 2008;50:607–12.
Buchmann L, Emami A, Wei JL. Primary head and neck Langerhans cell histiocytosis in children. Otolaryngol Head Neck Surg. 2006;135:312–7.
Jubran RF, Marachelian A, Dorey F, Malogolowkin M. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005;45:37–42.
Kudo K, Ohga S, Morimoto A, et al. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan. Bone Marrow Transplant. 2010;45(5):901–6.
Kwee TC, Kwee RM, Nievelstein RAJ. Imaging in staging of malignant lymphoma: a systematic review. Blood. 2008;111:504–16.
Hermans J, Krol AD, van Groningen K, et al. International prognostic index for aggressive non-Hodgkin’s lymphoma is valid for all malignancy grades. Blood. 1995;86:1460–3.
Ultmann JE, Moran EM. Diagnostic evaluation and clinical staging in Hodgkin’s disease: usefulness and problems of the Ann Arbor staging classification in primary staging and staging in relapse. Natl Cancer Inst Monogr. 1973;36:333–45.
Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin. 2005;55:368–76.
El-Badawy S, Aboulnaga S, Abou Gabal A, et al. Risk adapted combined modality treatment in children with Hodgkin’s disease: NCI, Cairo. J Egypt Natl Canc Inst. 2008;20:99–110.
Balwierz W, Moryl-Bujakowska A, Depowska T, et al. Influence of age on treatment results in children and adolescents with Hodgkin’s disease. Przegl Lek. 2004;61(Suppl 2):40–4.
Dorffel W, Luders H, Ruhl U, et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin’s disease in children and adolescents: analysis and outlook. Klin Padiatr. 2003;215:139–45.
Pinkerton CR. The continuing challenge of treatment for non-Hodgkin’s lymphoma in children. Br J Haematol. 1999;107:220–34.
Tsurusawa M. Non-Hodgkin’s lymphoma: treatment and outcome of children with advanced disease. Gan To Kagaku Ryoho. 1999;26:1050–5.
Regezi JA, Sciubba JJ, Jordan RCK. Lymphoid lesions. St Louis: Saunders an imprnt of Elsevier; 2003.
Narasimhan K, Arneja JS, Rabah R. Treatment of congenital epulis (granular cell tumour) with excision and gingivoperiosteoplasty. Can J Plast Surg. 2007;15:215–8.
Lucaya J, Sancho C, Bonnin J, Tormo R. Syndrome of multiple mucosal neuromas, medullary thyroid carcinoma, and pheocromocytoma: cause of colon diverticula in children. AJR Am J Roentgenol. 1979;133:1186–7.
Barry R, Pelser HH, Nel CJ, et al. Early thyroidectomy for medullary thyroid carcinoma in children and young adults with the multiple endocrine neoplasia type 2A (MEN 2A) syndrome. S Afr Med J. 1991;80:90–2.
Regezi JA, Sciubba JJ, Jordan RCK. Connective tissue lesions. St. Louis: Saunders an imprint of Elsevier; 2003.
Lack EE, Upton MP. Histopathologic review of salivary gland tumors in childhood. Arch Otolaryngol Head Neck Surg. 1988;114:898–906.
Gampper TJ, Morgan RF. Vascular anomalies: hemangiomas. Plast Reconstr Surg. 2002;110:572–85; quiz 586; discussion 587-578.
Mulliken JB, Young AE. Hemangiomas and malformations. Philadelphia: Saunders; 1988.
Brewis C, Pracy JP, Albert DM. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picibanil). Clin Otolaryngol Allied Sci. 2000;25:130–4.
Greinwald JH Jr, Burke DK, Sato Y, et al. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg. 1999;121:381–7.
Tronina SA, Bobrova NF, Khrinenko VP. Combined surgical method of orbital and periorbital hemangioma treatment in infants. Orbit. 2008;27:249–57.
Hohenleutner S, Badur-Ganter E, Landthaler M, Hohenleutner U. Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med. 2001;28:273–7.
Hall N, Ade-Ajayi N, Brewis C, et al. Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? Surgery. 2003;133:238–42.
Peters DA, Courtemanche DJ, Heran MKS, et al. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy. Plast Reconstr Surg. 2006;118:1441–6. https://doi.org/10.1097/01.prs.0000239503.10964.11.
Buckmiller LM. Update on hemangiomas and vascular malformations. Curr Opin Otolaryngol Head Neck Surg. 2004;12:476–87.
Ozen IO, Moralioglu S, Karabulut R, et al. Surgical treatment of cervicofacial cystic hygromas in children. ORL. 2005;67:331–4.
Rothfleisch JE, Kosann MK, Levine VJ, Ashinoff R. Laser treatment of congenital and acquired vascular lesions. A review. Dermatol Clin. 2002;20:1–18.
Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–22.
Vollmer E, Roessner A, Lipecki KH, et al. Biologic characterization of human bone tumors. VI. The aneurysmal bone cyst: an enzyme histochemical, electron microscopical, and immunohistological study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;53:58–65.
Rosa P, Hirsch DL, Dierks EJ. Congenital neck masses. Oral Maxillofac Surg Clin North Am. 2008;20:339–59.
Pryor SG, Lewis JE, Weaver AL, Orvidas LJ. Pediatric dermoid cysts of the head and neck. Otolaryngol Head Neck Surg. 2005;132:938–42.
Tracy TF Jr, Muratore CS. Management of common head and neck masses. Semin Pediatr Surg. 2007;16:3–13.
Sistrunk WE. Surgical treatment of cysts of the thyroglossal track. Ann Surg. 1920;71:121–2.
Zaebo R, Carlson ER. Malignancies of the jaws. St. Louis: Saunders and Imprint of Elsevier; 2003.
De Alava E, Gerald WL. Molecular biology of the Ewing’s sarcoma/ primitive neuroectodermal tumor family. J Clin Oncol. 2000;18:204–13.
Sandberg A, Bridge JA. Updates on cytogenetics and molecular genesis of bone and soft tissue. Cancer Genet Cytogenet. 2000;123:1–26.
West D. Ewing’s sarcoma family of tumors. Curr Opin Oncol. 2000;12:323–9.
Vaccani JP, Forte V, de Jong AL, Taylor G. Ewing’s sarcoma of the head and neck in children. Int J Pediatr Otorhinolaryngol. 1999;48:209–16.
Brook I. Diagnosis and management of parotitis. Arch Otolaryngol Head Neck Surg. 1992;118:469–71.
Brook I. Aerobic and anaerobic of suppurative sialoadenitis. J Med Microbiol. 2002;51:526–9.
Brook I. Acute bacterial suppurative parotitis: microbiology and management. J Craniofac Surg. 2003;14:37–40.
Camilleri AC, Lloyd RE. Lymphoepithelial cyst of the parotid gland. Br J Oral Maxillofac Surg. 1990;28:329–32.
Carlson E. Diagnosis and managemnet of salivary gland infections. Oral Maxillofac Surg Clin North Am. 2009;21:293–312.
Cascarini L, McGurk M. Epidemiology of salivary gland infections. Oral Maxillofac Surg Clin North Am. 2009;21:353–7.
Dave SP, Pernas FG, Roy S. The benign lymphoepithelial cyst and a classification system for lymphocytic parotid gland enlargement in the pediatric HIV population. Laryngoscope. 2007;117:106–13.
Fernandes RO, RA. Salivary gland disease. St Louis: Saunders an imprint of Elsevier; 2009.
Miloro M, Goldberg MG. Salivary gland infections. Philadelphia: W.B. Saunders; 2002.
Miloro M. Diagnosis and management of salivary gland disorders. St. Louis: Mosby; 2008.
Regezi J, Sciubba JJ, Jordan RCK. Salivary gland disease. Missouri: Elsevier; 2003.
Smith FB. Benign lymphoepithelial lesion and lymphoepithelial cyst of the parotid gland in HIV infection. Prog AIDS Pathol. 1990;2:61–72.
Townend J. Lymphoepithelial cyst of the parotid gland. Br J Oral Maxillofac Surg. 1991;29:138–9.
Nahelieli O. Salivary gland inflammatory disorders in children. Philadelphia: Saunders an imprint of Elsevier; 2004.
Catone G. Sublingual gland mucous escape:pseudocysts of the oro-cervical region. Oral Maxillofac Surg Clin North Am. 1995;7:431–78.
Elluru RG, Kumar M, et al. Physiology of the salivary glands. Philadelphia: Mosby Inc; 2005.
Marx R, Stern D. Non neoplastic salivary gland diseases. Chicago: Quintessence Publishing Co; 2003.
Kessler A, Handler SD. Salivary gland neoplasms in children: a 10-year survey at the Children’s Hospital of Philadelphia. Int J Pediatr Otorhinolaryngol. 1994;29:195–202.
da Cruz Perez DE, Pires FR, Alves FA, et al. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases. Int J Pediatr Otorhinolaryngol. 2004;68:895–902.
Luna MA, Batsakis JG, el-Naggar AK. Salivary gland tumors in children. Ann Otol Rhinol Laryngol. 1991;100:869–71.
Wenig B. Neoplasms of the salivary glands. Saunders an imprint of Elsevier; 2008.
Marx R, Stern D. Salivary gland neoplasms. Chicago: Quintessence Publishing Co; 2003.
Becelli R, Quarato D, Matarazzo G, et al. Surgical treatment of an extraparotid pleomorphic adenoma of minor salivary glands of the cheek. J Craniofac Surg. 2009;20:1604–6.
Kakimoto N, Gamoh S, Tamaki J, et al. CT and MR images of pleomorphic adenoma in major and minor salivary glands. Eur J Radiol. 2009;69:464–72.
Cerulli G, Renzi G, Perugini M, Becelli R. Differential diagnosis between adenoid cystic carcinoma and pleomorphic adenoma of the minor salivary glands of palate. J Craniofac Surg. 2004;15:1056–60.
Becelli R, Frati R, Cerulli G, et al. Pleomorphic adenoma of the minor salivary glands of the palate. J Exp Clin Cancer Res. 2001;20:25–8.
Toto PD, Hsu DJ. Product definition of pleomorphic adenoma of minor salivary glands. J Oral Pathol. 1985;14:818–32.
Chisholm DM, Waterhouse JP, Kraucunas E, Sciubba JJ. A quantitative ultrastructural study of the pleomorphic adenoma (mixed tumor) of human minor salivary glands. Cancer. 1974;34:1631–41.
Erlandson RA, Cardon-Cardo C, Higgins PJ. Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study. Am J Surg Pathol. 1984;8:803–20.
Ord R. Salivary gland tumors in children. Saunders an imprint of Elsevier: Philadelphia; 2004.
Rahbar R, Grimmer JF, Vargas SO, et al. Mucoepidermoid carcinoma of the parotid gland in children: a 10-year experience. Arch Otolaryngol Head Neck Surg. 2006;132:375–80.
Hicks J, Flaitz C. Mucoepidermoid carcinoma of salivary glands in children and adolescents: assessment of proliferation markers. Oral Oncol. 2000;36:454–60.
Marlowe JF, Hora JF. Parotid mucoepidermoid carcinoma in children. Laryngoscope. 1968;78:68–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kolokythas, A. (2022). Pediatric Maxillofacial Pathology. In: Miloro, M., Ghali, G.E., Larsen, P.E., Waite, P. (eds) Peterson’s Principles of Oral and Maxillofacial Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-91920-7_39
Download citation
DOI: https://doi.org/10.1007/978-3-030-91920-7_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-91919-1
Online ISBN: 978-3-030-91920-7
eBook Packages: MedicineMedicine (R0)